Madrigal Pharmaceuticals, Inc. (MDGL)

NASDAQ: MDGL · Real-Time Price · USD

447.79

-6.01 (-1.32%)

At close: Sep 9, 2025, 4:00 PM

448.73

+0.94 (0.21%)

After-hours: Sep 9, 2025, 4:31 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	2017 - 2019
Novel Therapeutics	180.13M	Log In	Log In	Log In	Log In	Upgrade
Novel Therapeutics Growth	122439.46%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	2017 - 2019
United States	180.13M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	122439.46%	Log In	Log In	Log In	Log In	Upgrade